(Q38082620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Hydroxylases as therapeutic targets in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

24 February 2020

main subject

0 references

author

Eoin P Cummins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Glen A Doherty

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Cormac T Taylor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

3

Cormac T Taylor

1 reference

28 August 2017

1

Eoin P Cummins

1 reference

28 August 2017

Glen A Doherty

2

1 reference

28 August 2017

18 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

378-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2013.9

24 February 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Crucial steps in the natural history of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Epidemiology and natural history of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Recent Insights Into the Genetics of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

CARD9 signaling in the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Cloning and characterization of human MUC19 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Interleukin-23/Th17 pathways and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Cytokine blockade in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Mucosal healing in inflammatory bowel diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Immunosuppression in inflammatory bowel disease: how much is too much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia: an alarm signal during intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia and gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Angiogenesis and blood vessel stability in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

21 January 2018

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-inducible factors in physiology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Mitochondria and cellular oxygen sensing in the HIF pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia inducible factor (HIF) function in innate immunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Interdependence of hypoxic and innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

HIF-1alpha is essential for myeloid cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1α and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-responsive transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

The role of NF-kappaB in hypoxia-induced gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

The anti-death machinery in IKK/NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

NF-κB, the first quarter-century: remarkable progress and outstanding questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

The updated biology of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Regulation of apoptosis during homeostasis and disease in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Importance of disrupted intestinal barrier in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

HIF-dependent induction of adenosine A2B receptor in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Selective induction of mucin-3 by hypoxia in intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Increased Expression of Hypoxia-Inducible Factor 1α in Coeliac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2013.9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419710%20AND%20SRC:MED&resulttype=core&format=json